CLINICAL_TRIALS
trial_result
· 2012-08-01
Clinical Trial Update: Folic Acid and Creatine as Therapeutic Approaches for Lowering Blood Arsenic [Phase 4]
Summary
A Phase 4 trial evaluated whether folic acid and creatine can lower blood arsenic in individuals with chronic arsenic exposure; the study has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Columbia University | Conditions: High Blood Arsenic Due to Chronic Arsenic Exposure | Phase 4 | Status: COMPLETED